COMMUNIQUÉS West-GlobeNewswire

Eckert & Ziegler BEBIG: Meeting Minutes Annual General Meeting

21/06/2018 - 15:49

Seneffe, June 21, 2018. The Minutes and all relevant documents regarding the Annual General Assembly 2018 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About Eckert [...]

Eckert & Ziegler BEBIG: Procès verbal de l'assemblée générale des actionnaires

21/06/2018 - 15:49

Seneffe, le 21 juin 2018. Le procès verbal ainsi que tous les documents relatifs à l'Assemblé Générale 2018 peuvent être téléchargés sur le site internet: http://www.bebig.com/home/investors/shareholder_information/ A [...]

Aino Health AB (publ): Aino HealthManager is live with ArcelorMittal

21/06/2018 - 15:03

Aino Health's IT platform HealthManager has gone live to support ArcelorMittal's operations in Neuwied, Germany. This is a joint implementation project with ArcelorMittal and Aino Health that is comprised of process [...]

Curetis Reports Results of the Annual General Meeting Held on June 21, 2018

21/06/2018 - 15:02

Curetis Reports Results of the Annual General Meeting Held on June 21, 2018 - All proposed AGM resolutions approved by shareholders Amsterdam, the Netherlands, Holzgerlingen, Germany and San Diego, CA, USA, June 21, [...]

Flexion Therapeutics Named one of Boston Business Journal’s Best Places to Work for the Second Year in a Row

21/06/2018 - 15:00

BURLINGTON, Mass., June 21, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been named as one of the Boston Business Journal’s “Best Places to Work” for the second year in a [...]

UPDATE - PolarityTE Appoints Paul Mann of Highbridge Capital to Chief Financial Officer

21/06/2018 - 14:32

Current PolarityTE CFO John Stetson will Become Chief Investment Officer of the Company and President of a New Strategic Arm—PolarityIS SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) [...]

Yield10 Researchers Publish Research in Plant Cell Reports Describing the Development of its Camelina Platform as a Model Crop for Novel Yield Trait Discovery

21/06/2018 - 14:30

WOBURN, Mass., June 21, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today [...]

Emisphere Development Update

21/06/2018 - 14:30

ROSELAND, N.J., June 21, 2018 (GLOBE NEWSWIRE) -- Novo Nordisk announced yesterday the completion and results of the phase 3a trials, PIONEER 4 and 7, with oral semaglutide, a once-daily oral formulation of the long- [...]

International Endeavors Benefits from Legalization of Marijuana in Canada

21/06/2018 - 14:30

TEMECULA, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- International Endeavors Corp (OTC:IDVV) announces plans to work with the largest marijuana growers in Canada now that the Canadian government approved the legalization [...]

Imagin Engages Kilmer Lucas for Cross-Border Investor Relations

21/06/2018 - 14:30

VANCOUVER, British Columbia and BOSTON, June 21, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) today announced that it has engaged [...]

Avinger’s Ocelot Technology Featured in Live Case Transmission at Complex Cardiovascular Catheter Therapeutics (C3) 2018

21/06/2018 - 14:30

C3 Curriculum Designed for Physicians Specializing in Interventional Cardiology, Vascular Surgery and Interventional Radiology REDWOOD CITY, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a [...]

GrowForce and Peguis First Nation announce cannabis joint venture

21/06/2018 - 14:14

First step in a Canada-wide expansion strategy with First Nations and Indigenous Peoples in the spirit of reconciliation and today’s National Aboriginal Day. WINNIPEG, Manitoba, June 21, 2018 (GLOBE NEWSWIRE) -- Today, [...]

ICC Labs Completes Its First Outdoor Harvest and Prepares to Produce Its First CBD Extracts

21/06/2018 - 14:09

VANCOUVER, British Columbia, June 21, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V:ICC) (Frankfurt:2Q9) is pleased to announce that it has completed its first outdoor harvest of hemp. The [...]

Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.

21/06/2018 - 14:00

New Role as the President involves leadership of the entire product portfolio Promotion reflects progress of Rigosertib to key data milestones NEWTOWN, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc [...]

ContraVir Pharmaceuticals Announces Data on Optimized Formulation of TXL™

21/06/2018 - 14:00

EDISON, N.J., June 21, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor

21/06/2018 - 14:00

Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in brain cancer PLYMOUTH MEETING, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: [...]

Cynata Reports Positive 28-day Data From Cohort B of Phase 1 Trial of CYP-001 in GvHD

21/06/2018 - 14:00

MELBOURNE, Australia, June 21, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce positive safety and efficacy data from a day 28 [...]

PolarityTE Appoints Paul Mann of Highbridge Capital to Chief Financial Officer

21/06/2018 - 14:00

Current PolarityTE CFO John Stetson will Become Chief Investment Officer of the Company and President of a New Strategic Arm—PolarityIS SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) [...]

Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia

21/06/2018 - 13:30

SHANGHAI, China and CUPERTINO, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]